Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2011-04-26
2011-04-26
Swartz, Rodney P. (Department: 1645)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S023100, C424S185100, C424S190100, C424S234100, C424S248100, C435S069100, C435S253100, C435S863000, C530S300000, C530S350000
Reexamination Certificate
active
07932373
ABSTRACT:
The invention provides polypeptides encoded by open reading frames present in the genome ofMycobacterium tuberculosisbut absent from the genome of BCG and diagnostic and prophylactic methodologies using these polypeptides.
REFERENCES:
patent: 6291190 (2001-09-01), Behr et al.
patent: WO97/09428 (1997-03-01), None
patent: WO9709429 (1997-03-01), None
patent: WO98/16645 (1998-04-01), None
patent: WO 98/16645 (1998-04-01), None
patent: WO98/16646 (1998-04-01), None
patent: WO 98/44119 (1998-10-01), None
patent: WO99/04005 (1999-01-01), None
Berthet et al., (1998), “A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10)”, Microbiol., 144:3195-3203.
Cole et al., “Mycobacterium tuberculosis H37Rv complete genome; segment 160/162”, Database EBI, Accession No. AL022120 XP002218539, referring to: Cole et al., (1998) “Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence”, Nature, 393:537-544.
Mahairas et al., 1996, “Molecular Analysis of Genetic Differences between Mycobacterium bovis BCG and Virulent M. bovis”, J. Bacteriol., 178(5):1274-1282.
EP Search Report dated Dec. 23, 2002.
EP Search Report dated Apr. 28, 2003.
Colangeli et al (2000) Infection and Immunity 68(2):990-993.
Lyaschencko et al. (1998) Infection and Immunity 66(8):3606-3610.
Manca et al. (1997) Infection and Immunity 65(1):16-23.
Manca et al. (1997) Infection and Immunity 65(12):4951-4957.
Ait-Kahaled et al., Tuberculosis: A Manual for medical students, Chapter 1—The basic science of tuberculosis (2003).
Harboe et al., “Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculsis virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG,” Infection and Immunity, 64:16-22 (Jan. 1996).
Opposition of GlaxoSmithKline Biologicals SA filed against European Patent Number EP1214008, Nov. 30, 2009.
Opposition of Statens Serum Institut filed against European Patent Number EP1214088, Jan. 21, 2010.
Lowenstein & Sandler PC
Swartz Rodney P.
University of Medicine and Dentistry of New Jersey
LandOfFree
Proteins expressed by mycobacterium tuberculosis and not by... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Proteins expressed by mycobacterium tuberculosis and not by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Proteins expressed by mycobacterium tuberculosis and not by... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2681605